Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Nathan Reticker-Flynn, PhD

Stanford University

Targeting lymph node-induced immune tolerance to treat metastatic breast cancer

Isidore Rigoutsos, PhD

Sidney Kimmel Medical College, Thomas Jefferson University

Presented by METAvivor Fundraisers in honor of all people living with MBC

Short RNAs Promote Metastases in an Ancestry-dependent Manner

Jennifer Rosenbluth, MD, PhD

University of California San Francisco

Presented in memory of Catherine Hill

Developing therapeutic strategies for metastatic inflammatory breast cancer using patient-derived organoids

PARTHA ROY, PhD

University of Pittsburgh

Pharmacological Inhibition of Myocardin-Family Proteins as a Novel Strategy to Combat Metastatic Breast Cancer

Davide Ruggero, PhD

University of California, San Francisco

Presented by the Minneapolis Metsquerade in memory of Erin Remme

Looking through a new lens: posttranscriptional regulation in metastatic breast cancer

Davide Ruggero, PhD

University of California, San Francisco

Presented by METAvivor Fundraisers in honor of all people living with metastatic breast cancer

ERα is a novel RNA-binding protein controlling a post-transcriptional program underlying breast cancer metastasis

Deepali Sachdev, BSc, MSc, PhD

Regents University

Presented by 2019 NYFW + #Cancerland in memory of Champagne Joy

Development of natural killer cell based tri-specific killer engagers (TriKEs) as novel immunotherapy for metastatic breast canc

Carol Sartorius, PhD

University of Colorado, Denver, CO

Endocrine therapy driven reprogramming of circulating tumor cell-platelet interactions in driving late metastatic spread of ER+ breast cancer

Amy Schade, PhD

Brigham & Women’s Hospital

Presented in memory of Noel Shubert Weaver, who passed away of triple negative metastatic breast cancer

Developing effective combination therapies for metastatic TNBC by co-targeting epigenetic and oncogenic enzymes

WILLIAM SCHIEMANN, PhD

Case Western Reserve University

Implementing a Forward Genetic Screen to Identify Novel Proto-Oncogenes Operant in Overcoming Metastatic Dormancy

WILLIAM SCHIEMANN, PhD

Case Western Reserve University

Implementing a Forward Genetic Screen to Identify Novel Proto-Oncogenes Operant in Overcoming Metastatic Dormancy

ILANA SCHLAM, MD, MPH

Dana-Farber Cancer Institute / Harvard Medical School

Presented by Western PA #LightUpMBC Color Walk, in loving memory of Lisa Szczepankowski

Phase 2 Study of ctDNA-Guided Temporary Treatment De-Intensification in Exceptional Responders with Metastatic Breast Cancer